X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
2013 accf/aha guideline (330) 330
association task-force (236) 236
index medicus (196) 196
cardiac & cardiovascular systems (186) 186
heart failure (147) 147
management (139) 139
humans (133) 133
american-college (120) 120
mortality (94) 94
female (61) 61
male (60) 60
percutaneous coronary intervention (60) 60
myocardial infarction (57) 57
cardiology (54) 54
heart diseases (52) 52
analysis (49) 49
patients (49) 49
elevation myocardial-infarction (48) 48
middle aged (48) 48
heart-failure (47) 47
risk factors (47) 47
abridged index medicus (46) 46
heart (46) 46
care and treatment (45) 45
aged (42) 42
cardiovascular disease (41) 41
medicine, general & internal (37) 37
outcomes (36) 36
task-force (35) 35
acute myocardial-infarction (34) 34
cardiac patients (34) 34
heart attacks (34) 34
treatment outcome (33) 33
pharmacology & pharmacy (31) 31
clinical trials (28) 28
heart attack (26) 26
prognosis (26) 26
randomized-trial (26) 26
electrocardiography (25) 25
hypertension (25) 25
therapy (25) 25
society (24) 24
diagnosis (23) 23
artery-disease (22) 22
coronary artery disease (22) 22
medical research (22) 22
research (22) 22
acute coronary syndromes (21) 21
cardiovascular (21) 21
cardiovascular diseases (21) 21
myocardial-infarction (21) 21
hospitalization (20) 20
medicine & public health (20) 20
review (20) 20
adult (19) 19
confidence intervals (19) 19
medicine, experimental (19) 19
peripheral vascular disease (19) 19
angioplasty (18) 18
health aspects (18) 18
heart failure - physiopathology (18) 18
left-ventricular dysfunction (18) 18
medical colleges (18) 18
preserved ejection fraction (18) 18
biomarkers (17) 17
cardiomyopathy (17) 17
diabetes (17) 17
disease (17) 17
heart failure - drug therapy (17) 17
heart failure - therapy (17) 17
patient outcomes (17) 17
quality of life (17) 17
acute coronary syndrome (16) 16
aged, 80 and over (16) 16
coronary heart disease (16) 16
ejection fraction (16) 16
focused update (16) 16
intervention (16) 16
myocardial infarction - therapy (16) 16
prevention (16) 16
retrospective studies (16) 16
usage (16) 16
clinical-outcomes (15) 15
coronary-artery-disease (15) 15
ejection (15) 15
epidemiology (15) 15
european-society (15) 15
reduced ejection fraction (15) 15
risk (15) 15
secondary prevention (15) 15
time factors (15) 15
transluminal angioplasty (15) 15
beta blockers (14) 14
coronary vessels (14) 14
diabetes mellitus (14) 14
double-blind (14) 14
infarction (14) 14
internal medicine (14) 14
medicine, research & experimental (14) 14
natriuretic peptides (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, ISSN 0735-1097, 04/2015, Volume 65, Issue 14, pp. 1455 - 1471
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 4, pp. 347 - 357
In a randomized trial of patients with type 2 diabetes, treatment with dapagliflozin, an SGLT2 inhibitor that promotes glucosuria, did not result in a higher... 
2013 ACCF/AHA GUIDELINE | MEDICINE, GENERAL & INTERNAL | SELECTIVE SGLT2 INHIBITOR | MANAGEMENT | HEART-FAILURE OUTCOMES | DISEASE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | KIDNEY | EMPAGLIFLOZIN | SOCIETY | Cardiovascular Diseases - etiology | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Type 2 diabetes | Safety and security measures | Dapagliflozin | Dosage and administration | Drug therapy | Cardiovascular diseases | Risk factors | Heart failure | Myocardial infarction | Cerebral infarction | End-stage renal disease | Heart attacks | Mortality | Diabetes mellitus | Cardiovascular disease | FDA approval | Patients | Glomerular filtration rate | Heart rate | Ischemia | Sodium | Arteriosclerosis | Ketoacidosis | Death | Diabetes | Kidney diseases | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | Abridged Index Medicus
Journal Article
JACC-CARDIOVASCULAR INTERVENTIONS, ISSN 1936-8798, 02/2017, Volume 10, Issue 4, pp. 315 - 324
OBJECTIVES The authors sought to compare the effectiveness of the different revascularization strategies in ST-segment elevation myocardial infarction (STEMI)... 
SYSTEMATIC REVIEWS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | MANAGEMENT | myocardial infarction | meta-analysis | RANDOMIZED-TRIAL | PRIMARY PCI | STRATEGIES | 2013 ACCF/AHA GUIDELINE | percutaneous coronary intervention | MULTI-VESSEL DISEASE | STEMI | ELEVATION MYOCARDIAL-INFARCTION
Journal Article
Canadian Journal of Cardiology, ISSN 0828-282X, 09/2019, Volume 35, Issue 9, pp. 1097 - 1105
Acute heart failure (HF) patients with renal insufficiency and risk factors for diuretic resistance may be most likely to derive incremental improvement in... 
2013 ACCF/AHA GUIDELINE | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | INITIATION | CLINICAL CHARACTERISTICS | AN ANALYSIS | ANTAGONIST THERAPY | Index Medicus
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 63, Issue 22, pp. 2356 - 2362
Journal Article
Annals of Pharmacotherapy, ISSN 1060-0280, 9/2019, Volume 53, Issue 9, pp. 905 - 915
Background: Heart failure (HF) is highly prevalent in the Veterans Affairs (VA) health care system and the leading cause of hospital discharges in the VA.... 
heart failure | IMPROVE | pharmacy consult | MANAGEMENT | QUALITY | interdisciplinary | CARE | 2013 ACCF/AHA GUIDELINE | CARDIOLOGY PRACTICES | veteran | SPIRONOLACTONE | PHARMACOLOGY & PHARMACY | OUTCOMES | ASSOCIATION | Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2019, Volume 73, Issue 24, pp. 3064 - 3066
The potential benefits of medical therapy for heart failure with reduced ejection fraction (HFrEF) are extraordinary. However, there remains a large gap... 
blood pressure | heart failure | reduced ejection fraction | medication | 2013 ACCF/AHA GUIDELINE | CARDIAC & CARDIOVASCULAR SYSTEMS | BLOOD-PRESSURE | Heart failure | Hypertension | Enzymes | Mortality | Clinical trials | Physiology | Blood pressure | Beta blockers | Patients | Heart diseases | Drug dosages | Clinical outcomes
Journal Article
13.